Zheng J, et al. - In this meta-analysis, researchers investigated the potential benefits and possible risks associated with Xuebijing when combined with ulinastatin for sepsis treatment. As per the results, Xuebijing when combined with ulinastatin was superior to both routine therapies and the single administration of either ulinastatin or Xuebijing. Finding thereby rendered a new therapeutic option for the treatment of sepsis.